MDLN Medline Inc. - Class A common stock
$36,30
Precio · May 20, 2026
Fundamentales a fecha de May 6, 2026
Rango 52S
$35–$51
9% of range
Calificación del Analista
BUY
34 analysts
Precio Objetivo
$52
+43% upside
P/E (TTM)
-4200.0
ROE
21.6%
Margen de Beneficio Neto
4.1%
MDLN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$36.30
Capitalización Bursátil
—
P/E (TTM)
-4200.0
BPA (TTM)
$-0.01
Ingresos (TTM)
$28.43B
Rendimiento div.
—
ROE
21.6%
Deuda/Capital
1.2
Rango 52S
$35 – $51
MDLN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$28.43B
2023-12-31
→
2025-12-31
BPA
$-0.01
2025-12-31
→
2025-12-31
Flujo de caja libre
$1.30B
2025-12-31
→
2025-12-31
Márgenes
4.1%
2025-12-31
→
2025-12-31
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
MDLN
Mediana de Pares
P/E (TTM)
-4200.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
MDLN
Mediana de Pares
Gross Margin (Margen Bruto)
26.4%
—
Operating Margin (Margen Operativo)
7.8%
—
Net Profit Margin (Margen de Beneficio Neto)
4.1%
—
ROA
3.1%
—
ROE
21.6%
—
ROIC
8.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
MDLN
Mediana de Pares
Debt / Equity (Deuda / Patrimonio)
1.2
—
Current Ratio (Ratio corriente)
4.3
—
Quick Ratio (Ratio Rápido)
2.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
MDLN
Mediana de Pares
Revenue YoY (Ingresos interanuales)
11.5%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
MDLN
Mediana de Pares
MDLN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
34 analistas
- Compra fuerte 12 35,3%
- Compra 15 44,1%
- Mantener 7 20,6%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
27 analistas · 2026-05-14
Mediana
$53.00
← Por Debajo de Todos los Objetivos
$36.30
Mín
$42.00
Máx
$60.00
Objetivo mediano
$53.00
+46,0%
Objetivo medio
$52.04
+43,4%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.10%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $0.33 | $0.30 | 0.03% |
| 31 de diciembre de 2025 | $0.43 | $0.25 | 0.18% |
Comparación con pares Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MDLN | — | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| MMED | — | — | — | — | — | — |
| HAE | $3.05B | 19.1 | 4.0% | 12.3% | 19.4% | 55.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 17
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | $28.43B | $25.51B | |
| Cost of Revenue | $20.91B | $18.53B | |
| Gross Profit | $7.52B | $6.98B | |
| R&D Expense | $80M | $67M | |
| SG&A Expense | $4.52B | $4.11B | |
| Operating Expenses | $5.31B | $4.83B | |
| Operating Income | $2.21B | $2.15B | |
| Interest Income | $133M | $280M | |
| Other Non-op | $-64M | $-43M | |
| Pretax Income | $1.25B | $1.25B | |
| Income Tax | $91M | $46M | |
| Net Income | $1.16B | · | |
| EPS (Basic) | $-0.01 | · | |
| EPS (Diluted) | $-0.01 | · | |
| Shares (Basic) | 810,000,000 | · | |
| Shares (Diluted) | 810,000,000 | · | |
| EBITDA | $3.22B | · |
Balance general 26
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $1.94B | $199M | |
| Receivables | $3.53B | $3.22B | |
| Inventory | $4.77B | $4.46B | |
| Other Current Assets | $438M | $398M | |
| Current Assets | $10.68B | $8.27B | |
| PP&E (Net) | $4.78B | $4.59B | |
| PP&E (Gross) | $5.94B | $5.46B | |
| Accum. Depreciation | $1.16B | $861M | |
| Goodwill | $8.08B | $8.06B | |
| Intangibles | $13.89B | $14.56B | |
| Other Non-current Assets | $23.03B | $23.11B | |
| Total Assets | $38.48B | $35.98B | |
| Accounts Payable | $961M | $869M | |
| Accrued Liabilities | $1.45B | $1.49B | |
| Short-term Debt | $1M | $2M | |
| Current Liabilities | $2.49B | $2.44B | |
| Capital Leases | $386M | $329M | |
| Other Non-current Liabilities | $682M | $598M | |
| Total Liabilities | $19.20B | $19.45B | |
| Long-term Debt | $12.56B | $16.49B | |
| Total Debt | $12.56B | · | |
| Paid-in Capital | $10.72B | · | |
| Retained Earnings | $-7M | · | |
| AOCI | $27M | $11M | |
| Stockholders' Equity | $10.74B | · | |
| Liabilities + Equity | $38.48B | $35.98B |
Flujo de Efectivo 14
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $1.01B | $977M | |
| Stock-based Comp | $76M | $61M | |
| Deferred Tax | $-20M | $-24M | |
| Amort. of Intangibles | $704M | $685M | |
| Other Non-cash | $-482M | · | |
| Operating Cash Flow | $1.74B | $1.77B | |
| CapEx | $447M | $354M | |
| Investing Cash Flow | $-474M | $-1.49B | |
| Stock Repurchased | $33M | $20M | |
| Net Stock Activity | $-33M | · | |
| Financing Cash Flow | $399M | $-1.61B | |
| Net Change in Cash | $1.69B | $-1.33B | |
| Taxes Paid | $62M | $101M | |
| Free Cash Flow | $1.30B | · |
Rentabilidad 8
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Gross Margin | 26.4% | · | |
| Operating Margin | 7.8% | · | |
| Net Margin | 4.1% | · | |
| Pretax Margin | 4.4% | · | |
| EBITDA Margin | 11.3% | · | |
| ROA | 3.1% | · | |
| ROE | 21.6% | · | |
| ROIC | 8.8% | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 4.3 | · | |
| Quick Ratio | 2.2 | · | |
| Debt / Equity | 1.2 | · | |
| LT Debt / Equity | 1.2 | · |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.8 | · | |
| Inventory Turnover | 4.5 | · | |
| Receivables Turnover | 8.4 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 11.5% | 9.8% |
Valoración (TTM) 4
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $28.43B | · | |
| Net Income TTM | $1.16B | · | |
| P/E | -4200.0 | · | |
| Earnings Yield | -0.02% | · |
Estado de resultados 16
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $7.35B | · | $6.64B | |
| Cost of Revenue | $5.51B | · | $4.82B | |
| Gross Profit | $1.84B | · | $1.82B | |
| SG&A Expense | $1.23B | · | $1.07B | |
| Operating Expenses | $1.42B | · | $1.25B | |
| Operating Income | $422M | · | $571M | |
| Interest Income | $29M | · | $34M | |
| Other Non-op | $1M | · | $0 | |
| Pretax Income | $291M | · | $338M | |
| Income Tax | $52M | · | $16M | |
| Net Income | · | · | $319M | |
| EPS (Basic) | $0.16 | · | · | |
| EPS (Diluted) | $0.16 | · | · | |
| Shares (Basic) | 819,000,000 | · | · | |
| Shares (Diluted) | 825,000,000 | · | · | |
| EBITDA | $676M | · | · |
Balance general 26
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $2.24B | $1.94B | · | |
| Receivables | $3.67B | $3.53B | · | |
| Inventory | $4.81B | $4.77B | · | |
| Other Current Assets | $463M | $438M | · | |
| Current Assets | $11.18B | $10.68B | · | |
| PP&E (Net) | $4.76B | $4.78B | · | |
| PP&E (Gross) | · | $5.94B | · | |
| Accum. Depreciation | · | $1.16B | · | |
| Goodwill | $8.08B | $8.08B | · | |
| Intangibles | $13.72B | $13.89B | · | |
| Other Non-current Assets | $23.08B | $23.03B | · | |
| Total Assets | $39.01B | $38.48B | · | |
| Accounts Payable | $932M | $961M | · | |
| Accrued Liabilities | $1.53B | $1.45B | · | |
| Short-term Debt | $1M | $1M | · | |
| Current Liabilities | $2.54B | $2.49B | · | |
| Capital Leases | · | $386M | · | |
| Other Non-current Liabilities | $625M | $682M | · | |
| Total Liabilities | $19.66B | $19.20B | · | |
| Long-term Debt | $12.57B | $12.56B | · | |
| Total Debt | $12.57B | · | · | |
| Paid-in Capital | $11.13B | $10.72B | · | |
| Retained Earnings | $122M | $-7M | · | |
| AOCI | $18M | $27M | · | |
| Stockholders' Equity | $11.27B | $10.74B | · | |
| Liabilities + Equity | $39.01B | $38.48B | · |
Flujo de Efectivo 12
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| D&A | $254M | · | $247M | |
| Stock-based Comp | $23M | · | $19M | |
| Deferred Tax | $37M | · | $-4M | |
| Amort. of Intangibles | $176M | · | $175M | |
| Operating Cash Flow | $412M | · | $682M | |
| CapEx | $96M | · | $98M | |
| Investing Cash Flow | $-96M | · | $-92M | |
| Stock Repurchased | $0 | · | $9M | |
| Net Stock Activity | $0 | · | · | |
| Financing Cash Flow | $-13M | · | $-9M | |
| Net Change in Cash | $296M | · | $590M | |
| Free Cash Flow | $316M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Gross Margin | 25.0% | · | · | |
| Operating Margin | 5.7% | · | · | |
| Pretax Margin | 4.0% | · | · | |
| EBITDA Margin | 9.2% | · | · | |
| ROIC | 1.5% | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 4.4 | · | · | |
| Quick Ratio | 2.3 | · | · | |
| Debt / Equity | 1.1 | · | · | |
| LT Debt / Equity | 1.1 | · | · |
Eficiencia 3
| Métrica | Tendencia | Q1 2026 | Q4 2025 | Q1 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.4 | · | · | |
| Inventory Turnover | 2.3 | · | · | |
| Receivables Turnover | 4.0 | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ingresos | $28.43B | $25.51B | $23.23B |
| Margen Bruto % | 26.4% | — | — |
| Margen Operativo % | 7.8% | — | — |
| Beneficio neto | $1.16B | — | — |
| EPS Diluido | $-0.01 | — | — |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Deuda / Patrimonio | 1.2 | — | — |
| Ratio corriente | 4.3 | — | — |
| Ratio Rápido | 2.2 | — | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $1.30B | — | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.